Metap Inc.: Metaverse Project GensoKishi Online Announces a Closed Alpha Ticket (Bronze) Lottery
GensoKishi Online -Meta World- is developed under the license of the well-known Japanese 3D MMO title “Elemental Knights Online.” The iconic game has a 14 year history and has accumulated a total of 8 million downloads worldwide. It already has a 3D MMORPG game with active users, with a fully-functioning 3D metaverse, that simultaneously connects users from around the world, be it smartphones, PCs, or video game consoles.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510005812/en/
GensoKishi Closed Alpha test (Graphic: Business Wire)
The game recently announced its collaboration with gaming legend Yoshitaka Amano to design their NFT collection.
Since the release of the GensoKishi website and various social media channels on December 2, 2021, GensoKishi have achieved a number of records to date. The governance token of the GensoKishi is currently more than 50 times higher than the initial listing price of Bybit, the first exchange to list MV token.
GensoKishi Online have opened up applications to enter the lottery for the Closed Alpha Bronze Tickets. Winners of the lottery will be provided exclusive access to GensoKishi’s Closed Alpha Test.
Click here to read details about Closed Alpha Test
Click here to visit the GensoKishi Online Metaworld Official Website
Campaign details regarding the Closed Alpha Testing Period
All participants of the Closed Alpha will receive a limited edition NFT to commemorate their participation in the Testing Period.
During the Closed Alpha Testing Period, an item called the "Alpha Hunter's Certificate" will drop at a certain probability rate when players defeat monsters during gameplay.
Each "Alpha Hunter's Certificate" will be treated as 1 point, and at the end of the first half and the second half of the Closed Alpha Testing Period, a ranking will be generated based on the number of “Alpha Hunter's Certificate” collected. The top 10 players of this rank will receive a limited edition NFT (equivalent to SR), and the top 11 to 100 players will receive a limited edition NFT (equivalent to SR).
How do you apply for the Closed Alpha Bronze Ticket lottery?
Please complete the tasks listed in here and submit your application via the application form.
Application Period for the Closed Alpha Bronze Ticket
- Start Date: May 3, 2022 12:00 (GMT+8)
- End Date: May 17, 2022 23:59 (GMT+8)
- Scheduled date of ticket distribution to winners: May 27, 2022
*Please note that applications cannot be accepted after the end date of the application period.
*Please note that the ticket distribution date is subject to change.
Closed Alpha Period
The specific schedule will be announced at a later date.
Apply now from here
*Check out the GensoKishi White Paper:
https://genso.game/pdf/WhitePaper_genso_EN.pdf
GensoKishi Online -META WORLD- Community
Official Site : https://genso.game/
Twitter: https://twitter.com/genso_meta
Discord: https://discord.gg/gensometa
Telegram: https://t.me/gensometamain
YouTube: https://www.youtube.com/channel/UCMi4wGMEWgC9VVps8d_NLDA
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005812/en/
Contact information
Metap Inc.
Maxi Kuan
Phone number: +886935312638
E-mail address: info@genso.game
About Business Wire
Business WireSubscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SimCorp Unites with FlexTrade to Add New EMS Ecosystem Partner28.3.2023 09:02:00 CEST | Press release
SimCorp, an independent provider of investment management solutions, has partnered with FlexTrade Systems, a global leader in high-performance multi-asset trade execution management systems (EMS), to extend SimCorp's Order Management System (OMS) capabilities by incorporating the cross-asset EMS functionality of FlexTrade's FlexTRADER EMS. This partnership addresses the increasing demand from trading teams for seamless integration and collaborative workflows between their OMS and EMS solutions. The integration will help optimize trading activities and assist in meeting best execution obligations. As part of the partnership, FlexTrade will join SimCorp's Open Platform program. The Open Platform program is designed to offer its client base frictionless access to innovative fintech solutions across the investment value chain. A key component of the new agreement will see the two firms work together to deliver enhanced, seamless connectivity between SimCorp's OMS, Order Manager, and FlexTr
euNetworks Forms Exclusive Partnership on CrossChannel Fibre System to Deliver Ultra-Low Latency Services Between London and Madrid28.3.2023 09:00:00 CEST | Press release
euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, today announced that it has entered into an exclusive partnership agreement with Crosslake Fibre UK Limited (“Crosslake”), an international network provider and developer of unique subsea and terrestrial fibre networks. This partnership relates to Crosslake’s new CrossChannel Fibre system and gives euNetworks exclusivity to deliver ultra-low latency services between the United Kingdom and Madrid on this system to the financial services community. euNetworks has also agreed to a strategic relationship, enabling the sale of dark fibre services by euNetworks using the system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230328005180/en/ Paula Cogan, CEO of euNetworks (Photo: Business Wire) CrossChannel Fibre is a 550km cable system with end-to-end fibre running between Slough, United Kingdom and Paris, France and is the first subsea
Adva Network Security protects TransnetBW’s communication network28.3.2023 09:00:00 CEST | Press release
Adva Network Security today announced that TransnetBW has deployed its ConnectGuard™ encryption technology with the Adtran FSP 3000 optical transport solution to establish a highly secure communication network in its service area. As the operator of an electricity transmission grid in southwestern Germany and a European interconnection partner, TransnetBW depends on the security and reliability of its communication network to ensure trouble-free operations. That’s why the company chose the FSP 3000 optical platform with Adva Network Security encryption technology, which has been approved by the German Federal Office for Information Security (BSI). This solution enables high-speed connections to be reliably and robustly protected, even against sophisticated cyberattacks. Planning and implementation of the highly secure infrastructure were carried out by Adva Network Security’s long-standing partner Syserso Networks, who will also provide ongoing support. This press release features mult
Fujirebio expands its assay menu in the field of neurodegenerative diseases with the launch of the fully automated Lumipulse ® G NfL CSF and Lumipulse ® G NfL Blood tests28.3.2023 07:00:00 CEST | Press release
H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE® G immunoassay systems. These CLEIA (chemiluminescent enzyme immunoassay) assays allow for the quantitative measurement of Neurofilament light (NfL) in human Cerebrospinal fluid (CSF) and plasma/serum, respectively, within just 35 minutes. The two assays are available for Research Use Only. “In 2022, we introduced three fully automated blood-based assays for the detection of pTau181, β-Amyloid1-42 and β-Amyloid1-40, and we are now proud to once again expand our neurodegenerative disease portfolio with the highly anticipated NfL biomarker,” Christiaan De Wilde, CEO of Fujirebio Europe and Global Head Neuro Business. “The assay menu offered by other industry leaders today is still limited and we are working diligently to create a solid lineup of tests for the entire neurodegenerative
Sofinnova Partners Launches Digital Medicine Strategy28.3.2023 06:00:00 CEST | Press release
Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced today that it has launched a new investment strategy focused on digital medicine. The strategy will be headed by Partners Edward Kliphuis and Simon Turner, who bring over a decade of experience investing in startups at the intersection of biology, data, and computation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230327005697/en/ Edward Kliphuis (left) and Simon Turner (right) (Photo: Business Wire) Sofinnova Digital Medicine will back entrepreneurs innovating at the cutting edge of technology and biology and help them scale to become global leaders. Like all the funds on Sofinnova’s platform, Sofinnova Digital Medicine will focus on developing the most promising innovations that address systemic challenges in healthcare and can profoundly improve the lives of patients worldwide. Antoine Pap
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom